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Abstract
Background:  Cardiac arrest survivors may experience hypoxic brain injury that results in
cognitive impairments which frequently remain unrecognised. This may lead to limitations in daily
activities and participation in society, a decreased quality of life for the patient, and a high strain for
the caregiver. Publications about interventions directed at improving quality of life after survival of
a cardiac arrest are scarce. Therefore, evidence about effective rehabilitation programmes for
cardiac arrest survivors is urgently needed. This paper presents the design of the ALASCA (Activity
and Life After Survival of a Cardiac Arrest) trial, a randomised, controlled clinical trial to evaluate
the effects of a new early intervention service for survivors of a cardiac arrest and their caregivers.
Methods/design: The study population comprises all people who survive two weeks after a
cardiac arrest and are admitted to one of the participating hospitals in the Southern part of the
Netherlands. In a two-group randomised, controlled clinical trial, half of the participants will receive
an early intervention service.
The early intervention service consists of several consultations with a specialised nurse for the
patient and their caregiver during the first three months after the cardiac arrest. The intervention
is directed at screening for cognitive problems, provision of informational, emotional and practical
support, and stimulating self-management. If necessary, referral to specialised care can take place.
Persons in the control group will receive the care as usual.
The primary outcome measures are the extent of participation in society and quality of life of the
patient one year after a cardiac arrest. Secondary outcome measures are the level of cognitive,
emotional and cardiovascular impairment and daily functioning of the patient, as well as the strain
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for and quality of life of the caregiver. Participants and their caregivers will be followed for twelve
months after the cardiac arrest.
A process evaluation will be performed to gain insight into factors that might have contributed to
the effectiveness of the intervention and to gather information about the feasibility of the
programme. Furthermore, an economic evaluation will be carried out to determine the cost-
effectiveness and cost-utility of the intervention.
Discussion: The results of this study will provide evidence on the effectiveness of this early
intervention service, as well as the cost-effectiveness and its feasibility.
Trial registration: Current Controlled Trials [ISRCTN74835019]
Background
The incidence of cardiac arrest is 1 – 2 per 1000 inhabit-
ants a year but differs according to country and region [1].
In the Netherlands, the incidence of cardiac arrests lies
between 0.6 – 0.9 per 1000 inhabitants per year, resulting
in approximately 16,000 cases of cardiac arrests each year
[2,3]. Resuscitation is attempted in 30 – 50% of the cases
[4]. The survival rate at discharge from the hospital after
attempted resuscitations is only 9 to 16% for out-of-hos-
pital resuscitations [2,5-7] and between 14 and 37% for
in-hospital resuscitations [8-11]. Faster access to external
automated defibrillators (AEDs) outside the hospital will
probably raise survival rates [4,12]. This will lead to an
increased number of cardiac arrest survivors and, thus, to
more patients having to live with the consequences of sur-
viving a cardiac arrest.
A cardiac arrest may lead to irreversible brain damage,
called posthypoxic encephalopathy or hypoxic brain
injury. Hypoxic brain injury often leads to cognitive or
emotional impairments, with memory disorders and
depressive symptoms being the most common com-
plaints [13-15]. As a result of this, the performance of
daily activities can be limited even six to twelve months
later, with almost a quarter of the people needing some
form of assistance in daily life [13,16-19]. Furthermore,
participation in society often decreases after a cardiac
arrest. For example, of the people who were working prior
to a cardiac arrest only 20% were able to resume their job
[20,21]. This all seems to result in a reduced quality of life
for both the patient and their caregiver and leads to a high
strain on the carer [18,20-22].
Unfortunately, although the number of problems is sub-
stantial, a large percentage of these problems, especially
the cognitive impairments, are not recognised or treated.
Currently, there exist no specific follow-up programmes
or nursing interventions for cardiac arrest survivors in the
Netherlands. In the international literature, only a few
programmes for cardiac arrest survivors were found. In a
study by Cowan et al., psychosocial nursing therapy
reduced two-year mortality in a group of cardiac arrest sur-
vivors [23]. This intervention consisted of physiological
relaxation (biofeedback), cognitive behavioral therapy
aimed at self-management and health education. Dough-
erthy et al. showed that an intervention, based on the
principles of social cognitive theory and the concerns of
patients and their partners, reduced physical symptoms
and anxiety and enhanced knowledge in persons who had
received an internal cardioverter defibrillator (ICD)
implantation [24-26]. However, this intervention had no
effect on health care use [25,26].
The diffuse brain injury and cognitive loss after a cardiac
arrest seems in many ways similar to that seen after trau-
matic brain injury. In a study on traumatic brain injury
patients, a routine follow up service resulted in a reduc-
tion in social morbidity and severity of post concussion
symptoms six months later [27]. Given that cognitive
impairment is a major problem in both hypoxic brain
injury and moderate head injury, a comparable type of
treatment could prove beneficial for patients after a car-
diac arrest.
Aims and hypotheses
The primary goal of the present study is to evaluate the
effectiveness of a new, early intervention service for survi-
vors of a cardiac arrest and their caregivers. Secondly, a
process evaluation will be performed to gain insight into
factors that might have contributed to the effectiveness of
the intervention and to gather information about the fea-
sibility of the programme. Finally, an economic evalua-
tion will determine the cost-effectiveness and cost-utility
of the intervention.
We anticipate that the prospective follow-up and support
provided by a specialised nurse will reduce the negative
consequences of a cardiac arrest and will result in a higher
level of participation in society and quality of life of the
cardiac arrest survivor. Furthermore, we expect that this
intervention will be cost-effective.BMC Cardiovascular Disorders 2007, 7:26 http://www.biomedcentral.com/1471-2261/7/26
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Methods/Design
Study design
The study presented in this paper is a randomised, con-
trolled clinical trial in which the effect of an early inter-
vention service will be investigated. Participants will be
followed over one year. During this year, three measure-
ments will take place, namely two weeks, three months
and twelve months after the cardiac arrest (see flow dia-
gram, Figure 1). The Medical Ethics Committee of Univer-
sity Hospital Maastricht/Maastricht University approved
the study protocol. The study is registered in a public trial
registry [ISRCTN74835019]. This study is part of a larger
research project, which also comprises a prospective and
prognostic cohort study.
Setting
Participants will be recruited from the coronary care units
and intensive care units of four hospitals in the Southern
part of the Netherlands, starting in April 2007. One of the
participating hospitals is a university hospital.
Study population
The population of this study consists of cardiac arrest sur-
vivors admitted to one of the participating hospitals,
including both survivors of out-of-hospital and in-hospi-
tal cardiac arrests (for in- and exclusion criteria, see Table
1) and their caregivers. In this study caregiver is defined as
partner, spouse, or significant other that is most closely
related to the patient.
The sample size calculation (two groups and one-sided
testing) results from research on traumatic brain injured
patients with regard to their participation in society
assessed using the Community Integration Questionnaire
(CIQ, described in more detail later). The mean (sd) total
score on the CIQ was 16.09 (sd = 4.20) [28]. An assumed
clinical relevant difference between groups of at least
10%, an alpha of 0.05 and a power (1-β) of 0.8 would
necessitate 84 patients in each group. With an estimated
loss to follow-up of 15%, based on earlier research in car-
diac arrest survivors, 200 participants are thought to be
necessary for the clinical trial [19,21,29]. This should be
achievable within three years, as the area served by the
participating hospitals covers approximately 1,000,000
inhabitants.
Recruitment and randomisation
Between three and ten days after the cardiac arrest the
patient and caregiver will be approached to participate in
the study by their treating physician. Standard procedures
concerning informed consent will be used. Both patients
and caregivers sign an informed consent form if they
decide to participate in the study. In case the patient is still
unconscious or incapacitated at the moment that
informed consent is needed, the caregiver will be asked to
give provisional informed consent. When the patient
regains consciousness, definitive informed consent will be
sought.
Participants will be randomly allocated to either the inter-
vention group or the control group. The randomisation
will take place after the baseline measurements (2 weeks
after the cardiac arrest) and will be performed centrally by
the project leader using a computerised block randomisa-
tion. The randomisation scheme includes prestratification
on two variables, namely hospital site and location of the
cardiac arrest (in-hospital versus out-of hospital). Two
series of opaque numbered envelopes will be prepared for
each hospital site (one for in-hospital and one for out-of-
hospital cardiac arrests), filled with a card indicating the
Table 1: Inclusion and exclusion criteria
Inclusion criteria
- All people who survive two weeks after a cardiac arrest
- Admitted in or to one of the participating hospitals
- Living within 50 km of one of the participating hospitals
- 18 years or older
- Sufficient knowledge of Dutch language
Exclusion criteria
- Life expectancy lower than 3 months (as assessed by the treating 
physician)
- Living in residential or institutional care prior to the cardiac arrest
Study design Figure 1
Study design.
Informed consent
Follow-up measurements
12 months
Cardiac arrest
Follow-up measurements
3 months
Intervention group
Early intervention service
Control group
Care as usual
Randomisation
Baseline measurements
2 weeks
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allocated group. After registration, the envelope will be
opened and the specialised nurse will be informed about
the patients that are allocated to the intervention group.
Group allocation and intervention
The intervention group will receive an early intervention
service delivered by a specialised nurse in addition to
usual health care available to all patients, whereas the
control group will only receive usual health care. The
intervention period will extend up to three months after
the cardiac arrest. During this period a specialised nurse
will provide one to six consultations for the patient
together with his or her caregiver (if present). The number
of consultations will be tailored for each individual partic-
ipant and will depend on the severity of the problems and
the needs and wished of the patient and their caregiver.
The consultations will take place in the hospital or at the
participants' home. In between the consultations the par-
ticipants have the opportunity to contact the nurses by
phone or email. During the intervention period the spe-
cialised nurse will screen for cognitive and emotional
problems. Next to that, information will be provided by
means of an information booklet and by discussing ques-
tions that the participants may have. Furthermore, emo-
tional and practical support will be offered and self-
management will be explained and promoted. A consult-
ant in rehabilitation medicine supervises the specialised
nurses. If necessary, referral to additional diagnostics or
specialised rehabilitation care can take place.
There will be no restrictions on possible co-interventions.
Participants assigned to the intervention group who do
not want treatment will still be approached for all the fol-
low-up measurements.
Data collection
Baseline measurements will be administered two weeks (=
T1) after the cardiac arrest, with further assessments at
three (= T2) and twelve months (= T3). The measurements
will be administered wherever the patient is at that time.
A research assistant, who will be blinded to the group allo-
cation, will perform the assessments.
To check for the effectiveness of blinding, the research
assistants will be asked after the last measurement to indi-
cate whether they think the participant belonged to the
intervention group or the control group.
Socio-demographical and medical variables
The following socio-demographical variables will be
recorded: Age, gender, nationality, marital status, living
condition, educational level, and work situation. The var-
iables related to the resuscitation and medical situation of
the patient that will be recorded are presented in Table 2.
Outcome measures for the effect evaluation
The primary outcome measures of this trial are participa-
tion in society and quality of life of the cardiac arrest sur-
vivor. The secondary outcome measures are cognitive,
emotional and cardiovascular impairment and daily func-
tioning of the cardiac arrest survivor, as well as the strain,
emotional functioning and quality of life of the caregiver.
The instruments that will be used to measure these
domains are presented in Table 3 and Table 4 and are
described in the next sections.
Primary outcome measures
Community Integration Questionnaire
The Community Integration Questionnaire (CIQ) is a 15-
item questionnaire that assesses the level of participation
in society [30]. The CIQ comprises three scales, namely
home integration, productive activity, and social integra-
tion.
Impact on Participation and Autonomy
The Impact on Participation and Autonomy (IPA) is a 39-
item questionnaire that focuses on two aspects of partici-
pation, namely perceived participation and the experience
of problems [31].
EuroQol 6D
The EuroQol 6D (EQ-6D) is a generic quality of life meas-
ure consisting of 6 items (mobility, self-care, usual activi-
ties, pain/discomfort, anxiety/depression and cognition)
each with three answer possibilities [32]. In addition, par-
ticipants are asked to give a general rating of their current
Table 2: Variables related to the resuscitation and the medical 
condition of the patient.
Location of cardiac arrest
Cardiac arrest witnessed
Direct start CPR
Use of external automated defibrillator (AED)
Number of defibrillations
Time intervals
- collapse – start CPR
- call – response
- collapse – first defibrillation
- collapse – return of spontaneous circulation
Glasgow Coma Score at admission
Initial cardiac rhythm
Presumed aetiology cardiac arrest
Cardiac treatment during hospital admission e.g. mild therapeutic 
hypothermia, PTCA, CABG, ICD
Ejection fraction at discharge
Duration of coma
Duration post-traumatic amnesia
Cardiovascular history
Co-morbidityBMC Cardiovascular Disorders 2007, 7:26 http://www.biomedcentral.com/1471-2261/7/26
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health state on a visual analogue scale, ranging from 0 to
100.
Medical Outcomes Study 36-item Short Form Health Survey
The Medical Outcomes Study 36-item Short Form Health
Survey (SF-36/RAND 36-item Health Survey) is a 36-item
generic quality of life questionnaire that measures several
domains of perceived health [33].
Quality Of Life after Brain Injury
The Quality Of Life after Brain Injury questionnaire
(QOLIBRI) is a brain injury specific quality of life meas-
ure. The QOLIBRI consists of 49 questions that measure
health related quality of life within six domains (physical
condition, thinking activities, feelings and emotions,
functioning in daily life, relationships and social/leisure
activities, current situation and future prospects) [34].
Secondary outcome measures
Cognitive Failures Questionnaire
The Cognitive Failures Questionnaire (CFQ) is a 25-item
questionnaire on self-reported cognitive failures [35].
Both the patient as well as his or her caregiver will be
asked to fill out this questionnaire to evaluate the cogni-
tive status of the patient.
Cognitive Log
The Cognitive Log (Cog-log) is a 10-item cognitive screen-
ing instrument [36]. It measures higher neurocognitive
Table 4: Outcome domains, measurement instruments and measurement moments for the caregivers
Measurement moments
Domain Measurement instrument Abbr. T1 T2 T3
Quality of life Short-Form-36 (RAND 36-item Health Survey) SF-36 X X X
EuroQol 6D EQ-6D X X X
Emotional functioning Hospital Anxiety and Depression Scale HADS X X X
Impact of Event Scale IES X X X
Fatigue Fatigue Severity Scale FSS X X
Caregiver Strain Caregiver Strain Index CSI X X X
T1 = 2 weeks after cardiac arrest
T2 = 3 months after cardiac arrest
T3 = 1 year after cardiac arrest
Table 3: Outcome domains, measurement instruments and measurement moments for the cardiac arrest survivors
Measurement moments
Domain Measurement instrument Abbr. T0 T1 T2 T3
Participation in society Community Integration Questionnaire CIQ X X X
Impact on Participation and Autonomy IPA X
Quality of life Short-Form-36 (RAND 36-item Health Survey) SF-36 X X X
EuroQol 6D EQ-6D X X X
Quality Of Life after Brain Injury QOLIBRI X X
Cognitive functioning Cognitive Failures Questionnaire CFQ X X X
Cognitive Log Cog-log X X X
Adult Memory and Information Processing Battery AMIPB X X X
Paragraph Recall PR X X X
Trail Making Test, part A + B TMT X X X
Verbal Fluency Test VFT X X X
Emotional functioning Hospital Anxiety and Depression Scale HADS X X X
Impact of Event Scale IES X X X
Cardiorespiratory functioning New York Heart Association Classification NYHA X X X
Fatigue Fatigue Severity Scale FSS X X
Basic daily activities Barthel Index BI X
Instrumental daily activities Frenchay Activity Index FAI X X X
T0 = situation prior to cardiac arrest (asked retrospectively at T1)
T1 = 2 weeks after cardiac arrest
T2 = 3 months after cardiac arrest
T3 = 1 year after cardiac arrestBMC Cardiovascular Disorders 2007, 7:26 http://www.biomedcentral.com/1471-2261/7/26
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processes including orientation, memory, concentration
and executive skills.
Adult Memory and Information Processing Battery Task A
The Adult Memory and Information Processing Battery
(AMIPB) Task A is a measure for information processing
speed [37]. In this test, the subject is asked to select the
second highest number in each row of five. The final score
is the number of correct choices made in two minutes.
Paragraph Recall
The Paragraph Recall (PR) is a test for immediate and
delayed verbal memory [38]. The subject is asked to recall
as much as possible from a paragraph, which is read to the
subject aloud. This will be performed both directly, and,
without warning, again 20 minutes later. To prevent inter-
ference with the paragraph from the previous measure-
ment, a different paragraph will be used each time.
Trail Making Test
The Trail Making Test (TMT) measures scanning, visuo-
motor tracking, divided attention and cognitive flexibility
[39]. The test is divided into two parts, part A and B. In
part A, the subject is asked to connect consecutively num-
bered circles on one work sheet as fast as possible. In part
B, the subject is asked to connect consequently numbered
and lettered circles. The time needed to complete part A
and part B is recorded.
Verbal Fluency Test
During the Verbal Fluency Test (VFT), the subject is asked
to name as many words from one semantic category, in
this case animals, in one minute [40].
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) is a
commonly used questionnaire, which was designed to
detect the presence of mild degrees of mood disorders in
non-psychiatric hospital outpatients [41]. The HADS con-
sists of 14 items, and has two sub-scales, namely depres-
sion and anxiety.
Impact of Event Scale
The Impact of Event Scale (IES) measures psychological
reactions that can take place after a traumatic event. The
IES has 15 items and explores the level of posttraumatic
stress by asking for intrusive and avoidance symptoms
[42,43].
New York Heart Association Classification
The New York Heart Association Classification (NYHA-
classification) is a functional classification system that
divides cardiac patients into four classes depending on
their limitation in physical activities [44].
Fatigue Severity Scale
The Fatigue Severity Scale (FSS) is a 9-item questionnaire
that measures experienced severity of fatigue symptoms in
daily activities [45].
Barthel Index
The Barthel Index (BI) is a widely used instrument that
measures basic (personal) activities of daily living (ADL).
The instrument consists of 10 items and measures to what
extent a person can perform basic ADL activities inde-
pendently [46].
Frenchay Activities Index
The Frenchay Activities Index (FAI) is an accepted measure
for instrumental ADL that reports on fifteen daily life
activities [47]. Compared to the Barthel Index, the meas-
ured activities are of a higher level, for example the prep-
aration of meals, doing groceries, making trips and
performing paid labour.
Caregiver Strain Index
The Caregiver Strain Index (CSI) is a 13-item, dichoto-
mous scale that has to be filled out by a partner, caregiver
or significant other [48]. The CSI measures strain related
to the provision of care.
Parameters for process evaluation
The intervention will be evaluated based on information
from the specialised nurses and the participants. First, the
intervention process will be evaluated based on informa-
tion provided by the specialised nurse. He/she will record
the following items: the actual number of consultations
(face-to-face, by telephone and by email), the direct time
related to each consultation, the indirect time related to
each consultation (administration, travel time), the provi-
sion of information per consultation, the use of the
screening tools, the kind of problems presented, number
of referrals, completion of the intervention according to
protocol and, in case of non-compliance, reason for non-
compliance. Second, after completion of the intervention
the participant and his/her caregiver will be asked to fill
out a questionnaire to evaluate the intervention.
Determination of costs
Data concerning costs will be gathered prospectively using
monthly cost-diaries [49]. All the participants receive cost-
diaries in which they are asked to note all their health care
utilisation during that month. To prevent non-compli-
ance, the research assistant will give a phone call at the
end of each month and will record the health care utilisa-
tion of that month. For the calculation of the total costs,
three categories can be distinguished, namely direct
health care costs, direct non-health care costs and indirect
costs. For the determination of the direct health care costs
the following variables will be recorded: duration admis-BMC Cardiovascular Disorders 2007, 7:26 http://www.biomedcentral.com/1471-2261/7/26
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sion in health care facility, visits physicians and other
health care providers and amount of prescribed medica-
tion. Direct non-health care costs that will be measured,
are the costs of informal health care, over-the-counter
medication, costs of health activities, hours of paid or
unpaid household help and special aids. The indirect
costs comprise loss of paid and unpaid work productivity
of the patient.
Statistical analysis
Effect evaluation
Descriptive techniques will be used to present data con-
cerning the participants, number of dropouts, losses-to-
follow up and the scores on the outcome measures.
To determine whether the patients participating in this
trial are representative for the population of cardiac arrest
survivors, the baseline characteristics between compliant
and non-compliant participants, as well as dropouts and
losses-to-follow up will be compared.
Before examining the effectiveness of the intervention, the
comparability of the two groups will be checked. Baseline
characteristics will be compared using independent sam-
ple T-test (normal distribution) or Mann Whitney U-test
(non-normal distribution), in case of a continuous varia-
ble. In case of a dichotomous variable a chi-square test
will be used.
The data from the evaluation study will be analysed
according to the intention-to-treatment principle. If either
T1 or T2 data are missing the 'last-observation-carried-for-
ward' principle will be used.
Multiple regression analysis, adjusted for possible differ-
ences in baseline characteristics or baseline scores, will be
applied to examine differences between the intervention
and the control group on the primary outcome measures
at T3 (one year after the cardiac arrest). If there is a differ-
ence between the groups, the effect size will be calculated.
Subgroup analysis will be performed for potential effect
modifiers.
To assess whether protocol deviations or care provided
outside the intervention have caused biases, the results of
the intention-to-treatment analysis will be compared to
the on-treatment analysis.
Process evaluation
The outcomes of the process evaluation will be reported
using descriptive techniques.
Economic evaluation
To determine the cost-effectiveness of the intervention a
statistical analysis of costs will be performed. The total
costs are calculated by adding up direct health care costs,
direct non-health care costs and indirect costs. Health care
costs are estimated using the Dutch guideline for cost
analysis in health care research [50]. The Friction Cost
Approach will be used to evaluate production losses, nec-
essary to determine indirect costs [50]. Discounting of
costs will take place if significant changes in health care
costs take place during the study period. As the distribu-
tion of costs might be skewed, differences in costs
between the intervention and care-as-usual will be calcu-
lated by means of bootstrapping, a method appropriate
for any distribution of data.
A multi-way sensitivity analysis will be performed to gain
insight into the generalisability of the economic evalua-
tion.
A cost-utility analysis will relate the difference in between
the intervention and care-as-usual to changes in utility.
This will result in costs per quality-adjusted-life-years
(QALY's).
Discussion
The main goal of the ALASCA trial is to evaluate a new
early intervention service for cardiac arrest survivors and
their caregivers. This is a relevant topic because evidence
on effective rehabilitation programmes for cardiac arrest
survivors is urgently needed. During the design of this
study many choices and selections were made, and four of
the more important ones will be discussed.
First, the intervention was designed especially for this
study. There are very few studies describing programmes
for people with hypoxic brain injury due to a cardiac
arrest. Consequently, we chose to model the intervention
upon evidence of effective interventions for people who
had traumatic brain injury, as there are many similarities
between hypoxic and traumatic brain injuries [27]. This
intervention designed for this study is a combination of a
psychosocial intervention and a process intervention. The
psychosocial aspects of the intervention are directed at
providing informational, emotional and practical support
and simulating self-management. The intervention is also
process intervention because it is directed at providing the
care needed fast and efficiently to each individual patient.
Second, the selection of our primary outcome measures,
participation in society and quality of life, may differ from
common primary outcome measures in cardiology
research. However, this is a common approach in rehabil-
itation medicine, where maximisation of participation in
society is one of the main goals [51]. We expect that
through the care provided in the new intervention,
patients will be able to reach a higher level of participa-
tion, as well as a higher quality of life.BMC Cardiovascular Disorders 2007, 7:26 http://www.biomedcentral.com/1471-2261/7/26
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Third, it may need some clarification why three quality of
life measures will be administered. The EQ-6D and the SF-
36 were chosen because they measure generic quality of
life and can be used in the cost-effectiveness analyses.
Next to that, these questionnaires have been used in many
other patient groups, which makes it possible to compare
the quality of life of cardiac arrest survivors to that of other
patient groups. The third quality of life measure is the
QOLIBRI, which is a brain injury specific questionnaire.
This questionnaire was included because it may have a
higher sensitivity to change in case of hypoxic brain injury
than both general quality of life measures.
Fourth, we explicitly chose to include the strain for and
quality of life of the caregiver in the secondary outcome
measures. Our impression is that being the partner of a
cardiac arrest survivor can imply a heavy burden. These
caregivers are at risk for developing stress and emotional
problems and this definitely needs more attention. There-
fore, the intervention is directed at both the patient and
their caregiver, who is expected to benefit from the early
intervention service as well.
To conclude, this paper describes the design of a ran-
domised, controlled clinical trial that will investigate the
effectiveness of a new early intervention service for cardiac
arrest survivors and their caregivers. The inclusion of the
participants started in April 2007 and will continue until
April 2010. The results of this study will provide evidence
on the effectiveness of this early intervention service, as
well as the cost-effectiveness and its feasibility. This will
give insight into the question whether it would be useful
to implement this early intervention service in the Dutch
health care system.
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